Evista

Evista (Raloxifene Hydrochloride) is a medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).

Evista is primarily used to prevent and treat osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in some tissues, such as bones, while blocking estrogen in others, like the uterus. This dual action helps to strengthen bones and reduce the risk of fractures. Evista is also sometimes used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease.

Common effects of Evista may include hot flashes, leg cramps, and fluid retention. Some users might experience swelling in the legs or feet. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Evista should be used with caution in individuals with a history of blood clots or those at risk for blood clots. It is important to inform your healthcare provider about any medical conditions or allergies before starting Evista. Regular monitoring may be required to ensure the medication is working effectively and safely.

Evista may interact with certain medications, including cholesterol-lowering drugs like statins and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Evista, as it may increase the risk of side effects.